RadNet Beats on Q3, Raises 2026 Imaging Center Guidance Again
RDNT sits 54% above its 52-week low of $50.82 on elevated volume (2.5× avg).
Summary
RadNet posted record Q3 revenue of $638.3M (+22.1%) and Adjusted EBITDA of $105.0M (+23.8%), then raised 2026 Imaging Center revenue, EBITDA and free cash flow guidance for the third time this year.
Key Events · Earnings and Guidance · RDNT
-
Record Q3 Revenue and EBITDA
Total revenue rose 22.1% to $638.3M from $522.9M, and Adjusted EBITDA rose 23.8% to $105.0M from $84.9M, with margin expanding to 16.5% from 16.2%.
-
2026 Guidance Raised Again
Imaging Center revenue guidance lifted to $2,385-$2,435M, Adjusted EBITDA to $350-$363M and Free Cash Flow to $120-$130M — the third upward revision this year after the Q1 and Q2 raises.
-
Digital Health EBITDA Slips
Digital Health revenue grew 32.6% to $32.9M but segment Adjusted EBITDA fell 11.8% to $3.0M; the pre-R&D EBITDA range was still raised to $11-$13M on expense management.
-
Balance Sheet Funds ONRAD Deal
Cash stood at $750.6M with Net Debt to Adjusted EBITDA of 1.66x at September 30, 2026, supporting the pending ONRAD acquisition of $350M cash plus stock announced October 26.
Analysis · RDNT · Industrial Applications And Services
RadNet's third quarter came in at record levels, and management lifted full-year Imaging Center targets for the third time this year. Revenue of $638.3M grew 22.1% and Adjusted EBITDA of $105.0M grew 23.8%, with margin up 23 basis points to 16.5%. The raised ranges — revenue to $2,385-$2,435M, Adjusted EBITDA to $350-$363M and Free Cash Flow to $120-$130M — tell investors the core imaging business is running ahead of plan, which matters because that segment funds the Digital Health build-out. The one soft spot is Digital Health, where segment Adjusted EBITDA fell 11.8% to $3.0M on heavier spending, though management raised that segment's pre-R&D EBITDA range to $11-$13M. With $750.6M of cash and leverage at 1.66x, the balance sheet supports the pending $350M cash ONRAD acquisition without new equity.
How filings like this one have moved
In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RDNT was trading at $78.29 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6B. The 52-week trading range was $50.82 to $85.84. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.